Press releases

23 Nov 2023

World’s first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment

News

23 Nov 2023

DNDi@20 charity run shines the spotlight on neglected diseases in Kenya

Videos

23 Nov 2023

Mycetoma: Neglected but not Forgotten

Scientific articles

21 Nov 2023

Safety and efficacy of paromomycin/ miltefosine/ liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study

PLOS Neglected Tropical Diseases

Scientific articles

21 Nov 2023

Clinical use of molecular methods for Trypanosoma cruzi infection in endemic and non-endemic countries: Benefits, limitations and challenges

Frontiers in Parasitology

Viewpoints

11 Nov 2023

DNDi: 20 years of delivering treatments for neglected patients

MSF Access Campaign Blog

Scientific articles

10 Nov 2023

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors

Science

Statements

7 Nov 2023

Seventh meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response

News

30 Oct 2023

MSF uses 1999 Nobel Peace Prize to help found pioneering not-for-profit drug development organization

Scientific articles

24 Oct 2023

Prognostic prediction models for clinical outcomes in patients diagnosed with visceral leishmaniasis: protocol for a systematic review

BMJ Open

Scientific articles

24 Oct 2023

Evaluación del cambio del algoritmo de diagnóstico serológico para la enfermedad de Chagas en Colombia

Pan American Journal of Public Health

Scientific articles

23 Oct 2023

Using (1,3)-β-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis

Mycoses